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In gastric cancer, the presence or absence of serosal invasion by cancer in the primary
lesion is an important prognostic factor.  Pathological findings are routinely determined
by hematoxylin-eosin (H&E) staining, but it is well known that micrometastasis or micro-
invasion are easily overlooked by H&E staining.  Cytokeratin (CK) proteins serve as reliable
markers for cells from epithelial origins.  The purpose of this study was to clarify the
usefulness of CK immunohistochemical staining in the detection of serosal microinvasion
in gastric cancer with subserosal invasion.  We examined 50 primary lesions from 50 gastric
cancer patients with subserosal invasion.  Two consecutive sections were prepared for
simultaneous staining with ordinary H&E and CK immunostaining with anticytokeratin
antibody (CAM 5.2), respectively.  Although there were no differences in the postoperative
survival rates between patients with or without microinvasion, serosal microinvasion was
detected in 8 (16%) of 50 patients by CK staining, including 1 patient whose invasion was
detected by both H&E and CK stainings.  CK immunostaining enabled us to make an
accurate and detailed diagnosis which we believe to be useful for detecting serosal micro-
invasion in the primary lesion in gastric cancer with subserosal invasion.
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The presence of serosal invasion by cancer within
the gastric wall is the most important prognostic
factor for patients with gastric cancer (Koga et al.,
1984; Kaibara et al., 1986; Baba et al., 1989), as well
as the extent of lymph node metastasis (Maruyama
et al., 1989; Siewert et al., 1993; Matsushita et al.,
1995).  Even when curative gastrectomy is perform-
ed on patients with gastric cancer with serosal in-
vasion, many patients die from recurrence of the
cancer and the prognosis of such patients remains
poor.  The development of peritoneal metastasis ac-
counts for more than half of all recurrences after
curative resection for gastric cancer with serosal
invasion (Kaibara et al., 1989).  When cancer cells
penetrate the tunica serosa of the stomach, exfoli-
ation of these cells from the surface of the primary
cancerous lesion into the peritoneal cavity is induc-
ed.  Many investigators have reported that patients
with gastric cancer with serosal invasion have free
cancer cells in the peritoneal cavity and these can-
cer cells are viable by enzymological and autoradi-
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ographycal examination (Nakajima et al., 1978;
Iitsuka et al., 1979; Tanida et al., 1982).  Additionally,
these cancer cells may be able to implant them-
selves and proliferate in the peritoneum causing
postoperative peritoneal metastasis.  Therefore,
precise diagnosis of the presence or absence of
serosal invasion by the primary gastric lesion is
very important for appropriate postoperative chem-
otherapy in order to prevent the development of
peritoneal metastasis.
Clinicopathologic diagnosis relies on hematoxy-
lin-eosin (H&E) staining in a respective section of
lymph nodes and primary lesions to ascertain the
presence of metastases and the depth of tumor inva-
sion.  However, it has been reported that discrete
cancer cells, namely occult micrometastases or
microinvasions are sometimes overlooked by rou-
tine examination with H&E staining (Trojani et al.,
1987; Ishida et al., 1997; Sasaki et al., 1997).
Immunohistochemical techniques with anti-
bodies against cytokeratin (CK) can identify lymph
node micrometastasis overlooked by H&E staining
in various solid malignancies (Sedmak et al., 1989;
Greenson et al., 1994; Maehara et al., 1996), because
CK proteins serve as reliable markers for cells of
epithelial origin.  In 1999, we reported that in gas-
tric cancer with submucosal invasion, CK immuno-
histochemical analysis can detect not only micro-
metastases in lymph nodes but also microinvasion
of the muscularis propria in primary lesions (Cai et
al., 1999).  Therefore, CK staining also seemed to be
useful in the detection of the serosal microinvasion
of gastric cancer with subserosal invasion.  The pur-
pose of the current study was to evaluate the use-
fulness of CK staining in the detection of microin-
vasion (serosal invasion) in gastric cancer with sub-
serosal invasion in which serosal invasion by the
cancer was undetectable by routine H&E staining.
Patients and Methods
Patients
Between 1985 and 1995, 64 patients with gastric
cancer with subserosal invasion underwent gast-
rectomy in the First Department of Surgery, Tottori
University Hospital.  We excluded 14 patients who
had metachronous or simultaneous primary malig-
nancies in organs other than the stomach and/or
patients whose primary lesions were limited to the
muscularis propria but classified as gastric cancer
with subserosal invasion by the presence of lym-
phatic or venous invasions by the cancer in the tela
subserosa apart from the primary lesion.  The sub-
jects of this study were 50 patients whose depth of
cancer invasion was limited to the tela subserosa of
the gastric wall.  There were 30 men and 20 women,
ranging in age from 31 to 80 years, with a mean age
of 63 years.  Clinicopathologic data were evaluated
according to the General Rules for Gastric Cancer
Study in Surgery and Pathology (Japanese Research
Society for Gastric Cancer, 1981).
CK-specific immunostaining of the primary
lesions
One to 4 paraffin-embedded blocks of the primary
lesions were prepared in each patient where the sub-
serosal invasion by the cancer had been identified
by the previous H&E-stained sections.  Serial sec-
tions of 4 µm in thickness from each block were
subjected to conventional H&E staining and CK-
specific immunostaining to allow comparison of re-
sults by the 2 methods in adjacent sections of each
primary lesion.  For controls, sections from 5 pa-
tients with mucosal cancer and 5 patients with sero-
sal invasion in the primary lesion were also stained
with the 2 methods in the same manner.
Immunohistochemical staining was perform-
ed by the streptavidin-biotin immunoperoxidase
method with a murine monoclonal antibody, CAM
5.2 (Becton Dickinson, San Jose, CA) against low-
molecular weight CK.  CAM 5.2 especially recog-
nizes intracellular CK component numbers 8 and
18, an intermediate filament representing the intra-
cellular network of the cytoskeleton that is express-
ed in simple epithelia.  In brief, dewaxed and de-
hydrated sections were heated in a microwave oven
(700 W) for 10 min for retrieval of antigens in the
specimens.  Endogeneous peroxidase was blocked
by incubation of samples with 3% hydrogen peroxi-
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Table 1. Clinicopathologic findings of 8 patients with serosal microinvasion
      Patient               Depth of invasion  Gross Tumor Histologic  Nodal          Vascular invasion
 Num-   Age (year)/  H&E CK finding   size     type   meta- Lymphatic Venous
  ber        gender  (cm)  stasis
   1 78/F se se Type 2 3.9 Undiff + + –
   2 73/M ss se Type 2 8.6 Diff + + +
   3 70/F ss se Type 2 8.0 Undiff + + +
   4 76/M ss se Type 2 7.0 Undiff – + +
   5 37/F ss se Type 3 2.2 Diff – – –
   6 80/M ss se Type 3 11.0 Undiff + + +
   7 42/M ss se Type 2 3.5 Undiff + + –
   8 75/F ss se Type 5 4.6 Undiff – + +
CK, cytokeratin; Diff, differentiated adenocarcinoma; F, female; H&E, hematoxylin and eosin; M, male; se, tunica
serosa; ss, tela subserosa; Undiff, undifferentiated adenocarcinoma.
Type 2, ulcerated carcinomas with sharply demarcated and raised margins; Type 3, ulcerated carcinomas without
definite limits, infiltrating into the surrounding wall; Type 5, non-classifiable carcinomas that cannot be classified into
any of the other types.
dase in 100% methanol.  The tissue sections were
then incubated with primary antibody CAM 5.2 at
25 µg/mL overnight at 4˚C.  The 2nd set of anti-
bodies, biotinylated against mouse immunoglobu-
lin, were applied with subsequent application of
peroxidase-labeled streptavidin.  Reaction products
were visualized with diaminobenzidine as the chro-
mogen and sections were counterstained with meth-
yl green.  Tris-buffered saline was used instead of
the primary antibody for negative controls.
The H&E-stained slides were first assessed for
the determination of the depth of invasion in the pri-
mary lesion, followed by the assessment of immuno-
stained slides.  Microinvasion in the primary lesions
was defined as the presence of isolated or clustered
cancer cells exposed to the tunica serosa of the
stomach wall.
Statistical analysis
Statistical analysis was performed by the chi-square
test to examine the relationships between microin-
vasion and the clinicopathologic characteristics of
the primary lesion.  For analysis of survival after
gastrectomy, we used the Kaplan-Meier method
and the generalized Wilcoxon test for the statistical
significance.  A P value less than 0.05 was consid-
ered to be significant.  None of the patients was lost
during follow-up.
Results
The controls used were 5 CK-stained specimens of
mucosal cancer whose cancerous lesions were con-
firmed to be limited to the mucosal layer without
microinvasion of the submucosal layer.  Moreover,
the non-cancerous normal epithelium was also CK-
positive in all specimens.  Five specimens stained
with CK of serosally exposed cancer confirmed
complete exposure of cancer cells on the tunica se-
rosa of the stomach.  Further, some mesothelial
cells and/or smooth muscle were stained with CK
unexpectedly in some specimens.
Table 1 summarizes the results of the current
study in 50 gastric cancer patients with subserosal
invasion in which serosal invasion was undetect-
able by H&E staining.  Eight patients (16%) were
determined to have serosal microinvasion, includ-
ing 1 patient (Patient 1) whose serosal invasion was
detected by both H&E and CK stainings (Figs. 1a
and b).  In 7 patients (Patients 2 to 8), serosal micro-
invasion was detected by CK staining, but H&E
staining failed to detect it, as shown in Figs. 1c and d.
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Fig. 1.  Comparison of the results between H&E and CK stainings.
a and b: Example of stained primary lesion after staining with H&E (a) and CK (b) (2.5 × 10 each).  Serosal
microinvasion was detected by both H&E and CK stainings (Patient 1).
c and d: Example of stained primary lesion after staining with H&E (c) and CK (d) (2.5 × 10 each).  Serosal
microinvasion was not detected by H&E staining but by CK immunostaining.
e and f: Example of stained primary lesion after staining with H&E (e) and after staining with CK (f) (2.5 × 10
each).  Serosal microinvasion was not detected by either H&E or CK staining.
c d
a b
e f
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Fig. 2.  Postoperative survivals (Kaplan-Meier method).
se, tunica serosa.
Table 2.  Serosal microinvasion in the primary lesion and clinicopathologic characteristics
         Variable Number          Microinvasion of the serosa P value
of        Positive (%)    Negative (%)
patients             [n = 7]        [n = 42]
Age (year) 49                      64.7 ± 17.5          62.2 ± 10.9
Gender (male/female)                                     30/19 4/3 26/16
Gross finding Type 0, 1   8 0   8
Type 2 24 4 (17) 20 (83)
Type 3 13 2 (15) 11 (85)
Type 4   1 0   1
Type 5   3 1 (33)   2 (67) 0.6423
Histologic type Differentiated 19 2 (11) 17 (89)
Undifferentiated 30 5 (17) 25 (83) 0.5495
Depth of invasion* ssα, β 26 3 (12) 23 (88)
ssγ 23 4 (17) 19 (83) 0.5590
Nodal metastasis Negative 19 3 (16) 16 (84)
Positive 30 4 (13) 26 (87) 0.8108
Lymphatic invasion Negative 15 1 (  7) 14 (93)
Positive 34 6 (18) 28 (82) 0.3114
Venous invasion Negative 17 2 (12) 15 (88)
Positive 32 5 (16) 27 (84) 0.7132
Types 0 and 1, superficial, flat tumors with or without minimal elevation or depression and  polypoid tumors,
sharply demarcated from the surrounding mucosa, usually attached on a wide  base, respectively; Type 4, diffusely
infiltrating carcinomas in which ulceration is usually not a marked feature; Type 2, 3 and 5, see footnote to Table 1.
* When cancerous invasion extends to the tela subserosa (ss), the growth patterns can be divided into 3 categories;
ssα, expansive growth pattern with a distinct border; ssβ,  intermediate pattern between ssα and ssγ; ssγ, infiltrative
growth pattern with an ill-defined border.
Six of these 8 patients with serosal microinvasion
had undifferentiated adenocarcinoma as a histolo-
gic type of gastric cancer.  The remaining 42 pa-
tients were determined to have no serosal micro-
invasion by either H&E or CK-staining (Figs. 1e
and f).
Clinicopathologic characteristics of the 7 pa-
tients with serosal microinvasion in the primary le-
sions (Patient 1, whose serosal invasion was de-
tected by H&E and CK stainings, was excluded)
were compared with those of 42 patients without it
(Table 2).  Microinvasion was found to be more fre-
quent in undifferentiated types of cancer and in pa-
tients with lymphatic invasion by cancer.  However,
there were no statistical differences between the 2
groups among any variables.
Figure 2 compares the 5-year Kaplan-Meier
survival curves for 7 patients with and 42 patients
without microinvasion. There was no difference in
survivals between the 2 groups.
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Discussion
Identification of lymph node metastasis is an im-
portant factor in predicting postoperative survival
of patients with gastric cancer, and H&E staining
has been widely used for this purpose.  However,
immunohistochemical techiques with antibodies
against CK can identify micrometastases in lymph
nodes missed during routine H&E staining from
gastric cancer (Maehara et al., 1996; Ishida et al.,
1997; Maeta et al., 1998; Cai et al., 1999), colo-rectal
cancer (Greenson et al., 1994; Adell et al., 1996;
Sasaki et al., 1997) and breast cancer (Sedmak et al.,
1989; Dowlatshahi et al., 1997).  Because CK pro-
teins are essential constituents of the cytoskeleton
of both normal and malignant epithelial cells in
lymph nodes, they serve as reliable markers for the
epithelial origin of cells.  Patients with these CK-
positive cells in lymph nodes have a significantly
decreased postoperative survival time.
Since it is known that in patients with gastric
cancer, the depth of cancer invasion within the
stomach wall is also an important prognostic factor,
as well as nodal metastases, we reported previously
that immunohistochemical staining with CK was
useful for the detection of microinvasion of the
muscularis propria in gastric cancer with submuco-
sal invasion (Cai et al., 1999).  In gastric cancer pa-
tients with serosal invasion, serosally exposed can-
cer cells are easily isolated in the peritoneal cavity,
and these cells proliferate as a peritoneal metastasis.
On cytologic examination of peritoneal lavage fluid
immediately after laparotomy at the time of sur-
gery, free intraperitoneal cancer cells are frequently
found in such patients.  Kaibara et al. (1986) re-
ported that there were close relationships both be-
tween the rate of detection of intraperitoneal free
cancer cells and the area of serosal invasion, and be-
tween the area of serosal invasion and prognosis in
patients with gastric cancer with serosal invasion.
Therefore, in patients with gastric cancer, the pres-
ence of serosal invasion implies a very high risk for
the development of postoperative peritoneal meta-
stasis.
In the current study, the usefulness of CK
staining was examined in order to find out whether
it can detect serosal microinvasion in gastric cancer
with subserosal invasion, because serosal microin-
vasion may be overlooked by routine H&E staining.
As a result, microinvasion was detected in 8 pa-
tients, including 1 whose microinvasion was detect-
ed by both CK and H&E stainings.  However, sero-
sal microinvasion was not a significant prognostic
factor, and there were no differences in postopera-
tive survivals between patients with or without
microinvasion.  The area of microinvasion detected
by CK staining in this series may be too narrow to
both introduce the isolation of free cancer cells into
the peritoneal cavity and affect postoperative sur-
vival.
Based on our findings above, it may be sug-
gested that there is no clinical implication in detect-
ing serosal microinvasion using CK staining.  How-
ever, the important point is how to make an effort to
diagnose the presence or absence of serosal in-
vasion and/or microinvasion accurately and pre-
cisely.  In our series, the number of patients was too
small to answer the question of whether the detec-
tion of serosal microinvasion by CK staining is im-
portant or not, and thus a multi-institutional study
using a large number of patients is necessary.  Nev-
ertheless, induction of the CK staining as in this
series in the pathohistological diagnosis of serosal
microinvasion may be the 1st trial ever for gastric
cancer.  We believe that H&E and CK stainings
should be seriously considered for simultaneous use
in the accurate determination of both nodal metasta-
sis and depth of cancer invasion.
Although CK is a reliable marker of cells from
epithelial origins, Makin et al. (1984) reported that
there were some exceptions to negative staining,
such as normal stratified squamous esophageal epi-
thelia and of positive staining of cells from non-
epithelial origins, such as smooth muscle and meso-
thelium.  As indicated in this series, when CK im-
munostaining is used for detecting serosal micro-
invasion, careful attention should be paid to the un-
expected exceptional positive staining of meso-
thelial one-layered cells.
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